GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 726 filers reported holding GLAXOSMITHKLINE PLC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $50,791,000 | +19.3% | 1,300 | +8.3% | 0.06% | +41.3% |
| Q4 2017 | $42,564,000 | -12.6% | 1,200 | 0.0% | 0.05% | -22.0% |
| Q3 2017 | $48,720,000 | -9.6% | 1,200 | -4.0% | 0.06% | -6.3% |
| Q2 2017 | $53,900,000 | -1.7% | 1,250 | -3.8% | 0.06% | +1.6% |
| Q1 2017 | $54,808,000 | +9.5% | 1,300 | 0.0% | 0.06% | +12.7% |
| Q4 2016 | $50,063,000 | -47.1% | 1,300 | -40.7% | 0.06% | -22.5% |
| Q3 2016 | $94,584,000 | -0.5% | 2,193 | 0.0% | 0.07% | -45.0% |
| Q2 2016 | $95,044,000 | +6.9% | 2,193 | 0.0% | 0.13% | +14.2% |
| Q1 2016 | $88,926,000 | +0.5% | 2,193 | 0.0% | 0.11% | +7.6% |
| Q4 2015 | $88,487,000 | +79.5% | 2,193 | +71.1% | 0.10% | +2.9% |
| Q3 2015 | $49,293,000 | +21.1% | 1,282 | +31.2% | 0.10% | +161.5% |
| Q2 2015 | $40,692,000 | -2.0% | 977 | +8.6% | 0.04% | -4.9% |
| Q1 2015 | $41,535,000 | – | 900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |